Table1_Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis.DOCX

Background<p>Abraxane plays a crucial role in the treatment of various types of cancer, despite the considerable attention it has garnered for its adverse drug events (ADEs). Nevertheless, there is currently a significant lack of comprehensive real-world pharmacovigilance studies on the ADEs a...

Full description

Saved in:

Bibliographic Details
Main Author:	Yuanqiong Duan (16022084) (author)
Other Authors:	Ying Wang (11406) (author), Shentao Lu (19956195) (author), Mei Zeng (293866) (author), Lubin Liu (17619118) (author), Qian Dai (2640862) (author), Rutie Yin (12077955) (author)
Published:	2024
Subjects:	Pharmacology Basic Pharmacology Clinical Pharmacology and Therapeutics Clinical Pharmacy and Pharmacy Practice Pharmaceutical Sciences Pharmacogenomics Toxicology (incl. Clinical Toxicology) Pharmacology and Pharmaceutical Sciences not elsewhere classified albumin-bound paclitaxel adverse drug events FDA adverse event reporting system signal mining pharmacovigilance analysis real-world study
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Table1_Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis.DOCX

Similar Items